Geron

Patent cliffs & loss of exclusivity

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. RYTELOIMETELSTAT SODIUMSmall mol.Jun 2039
  2. RYTELOIMETELSTAT SODIUMSmall mol.Jun 2039

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.